The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer
T Hemdan et al, 2014, British Journal of Cancer CrossRef
An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance
Amelia L. Parker et al, 2017, International Journal of Molecular Sciences CrossRef
Intrinsic and Extrinsic Factors Affecting Microtubule Dynamics in Normal and Cancer Cells
Filip Borys et al, 2020, Molecules CrossRef
Tubulin Proteins in Cancer Resistance: A Review
Mohammad Amjad Kamal et al, 2020, Current Drug Metabolism CrossRef
Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer
Wei Nie et al, 2015, Laboratory Investigation CrossRef
Movers and shakers: cell cytoskeleton in cancer metastasis
C M Fife et al, 2014, British Journal of Pharmacology CrossRef
Unveiling microtubule dynamics in lung cancer: Recent findings and prospects for drug delivery and treatment
Megumi Nishitani Yukuyama et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
Targeting the cytoskeleton against metastatic dissemination
Carmen Ruggiero et al, 2021, Cancer and Metastasis Reviews CrossRef
Potential therapeutic targets shared between leishmaniasis and cancer
Sajad Rashidi et al, 2021, Parasitology CrossRef
High TUBB2A expression in childhood T‐ALL is correlated with the clinical outcome
Khusan Khodzhaev et al, 2020, International Journal of Laboratory Hematology CrossRef
Sulforaphane metabolites inhibit migration and invasion via microtubule-mediated Claudins dysfunction or inhibition of autolysosome formation in human non-small cell lung cancer cells
Zhongnan Zheng et al, 2019, Cell Death & Disease CrossRef
The Prognostic Role of the Class III β-Tubulin in Non-Small Cell Lung Cancer (NSCLC) Patients Receiving the Taxane/Vinorebine-Based Chemotherapy: A Meta-Analysis
Yan-Long Yang et al, 2014, PLoS ONE CrossRef
Use of TUBB3 for Patient Stratification and Prognosis in Lung Cancer
Jan Nyrop Jakobsen et al, 2015, Lung Cancer Management CrossRef